FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32687911000001106: Loxapine 9.1mg/dose inhalation powder 1 dose (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-May 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
99840401000001116 Loxapine 9.1mg/dose inhalation powder 1 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
99840501000001117 Loxapine 9.1mg/dose inhalation powder 1 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Loxapine 9.1mg/dose inhalation powder 1 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Loxapine 9.1mg/dose inhalation powder 1 dose Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Loxapine 9.1mg/dose inhalation powder 1 dose Has VMP Loxapine 9.1mg/dose inhalation powder true Inferred relationship Existential restriction modifier
Loxapine 9.1mg/dose inhalation powder 1 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Loxapine 9.1mg/dose inhalation powder 1 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Loxapine 9.1mg/dose inhalation powder 1 dose Has specific active ingredient Loxapine true Inferred relationship Existential restriction modifier
Loxapine 9.1mg/dose inhalation powder 1 dose Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Adasuve 9.1mg/dose inhalation powder (Galen Ltd) 1 dose Is a True Loxapine 9.1mg/dose inhalation powder 1 dose Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start